Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -3.36% | -15.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.36% | -15.22% | |||
| Cost of Revenue | 66.94% | -69.12% | |||
| Gross Profit | -18.52% | 35.93% | |||
| SG&A Expenses | -16.64% | 5.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.88% | -11.98% | |||
| Operating Income | 15.44% | 9.05% | |||
| Income Before Tax | 12.71% | 0.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.71% | 0.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.71% | 0.25% | |||
| EBIT | 15.44% | 9.05% | |||
| EBITDA | 13.66% | 9.38% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.12% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||